Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001013594-25-001064
Filing Date
2025-08-14
Accepted
2025-08-14 21:32:11
Documents
1
Period of Report
2025-08-14

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 3404
  Complete submission text file 0001013594-25-001064.txt   5405
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Issuer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 15 EXCHANGE PLACE JERSEY CITY NJ 07302
Business Address 15 EXCHANGE PLACE JERSEY CITY NJ 07302 212-956-2221
PAULSON & CO. INC. (Reporting) CIK: 0001035674 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-14956 | Film No.: 251222205